Single Cell Analysis Market Size, Share & Trends Analysis Report By Product, By Application (IVF, Cancer, Immunology, Neurology, Stem Cell, Non-invasive Prenatal Diagnosis), By End Use, And Segment Forecasts, 2020 - 2027
The global single cell analysis market size is expected to reach USD 8.02 billion by 2027, registering a CAGR of 16.9% during the forecast period, according to a new report by Grand View Research, Inc. Advancements in molecular techniques which resulted in higher accuracy, ability to perform multiple omics analyses in one cell, and automation, has lowered the barriers for implementation of single-cell analysis techniques across various end-use settings. As a result, companies are investing in introducing novel solutions to accelerate the identification and quantification of genetic information in individual cells for research programs, thereby contributing to revenue growth in this market.
This technology has addressed several research challenges with respect to biological intricacies in stem cell biology, tumor biology, immunology, and other therapeutic areas. This leads to improved therapeutic decision-making with regards to precision medicine, thereby driving the adoption of these assays in personalized therapeutic development.
The growth in research publications depicts the increasing R&D investments. Since R&D activities are considered as the foundation of innovation, investments in R&D activities signify a healthy growth prospect for the single cell analysis market. Moreover, the establishment of new single cell genomics centers in the past years is anticipated to boost the uptake of instruments and consumables for single cell analysis, thus driving the growth.
Further key findings from the report suggest:
- Consumables accounted for the major revenue share in 2019 owing to the continuous demand and repeated purchase of products offered under this segment
- Introduction of automated instruments is anticipated to boost the revenue growth for instrument segment
- Cancer biology is one of the majorly benefitted applications of single-cell analysis
- Investigation at the individual cellular level has resolved several concerns associated with tumor mechanism and drug response, which has fomented the uptake of this technology analysis in cancer biology
- Single cell analysis is being researched and employed across various end-use settings ranging from academic research institutes to biopharmaceutical companies
- However, since it is in infant stage in the current mark, majorly it is employed with research end-user settings
- Hospitals and diagnostic laboratories segment is expected to emerge as the lucrative source of revenue in the forthcoming years, due to the ongoing efforts to bridge the gap for implementation of OMICs technology from research laboratories to clinical settings
- North America dominated the global revenue share in 2019, owing to the continuous strategies undertaken in U.S. for development of robust therapies and advance the disease diagnosis
- Asia Pacific is estimated to expand at the fastest CAGR over the forecast period with China & India at the forefront. A high number of CAR T clinical trials in China and low operating cost for clinical trials in India would contribute to the anticipated growth
- Some key players operating in the Single cell analysis market are Illumina, Inc.; Qiagen N.V.; Thermo Fisher Scientific, Inc.; Merck Millipore GmbH; Bio-Rad Laboratories, Inc.; Fluidigm, BGI; 10x Genomics, Inc.; and Novogene Corporation
- Companies like Illumina and Qiagen are expected to gain competitive advantage on account of their wide sequencing portfolio. On the other hand, companies like 10x Genomics, Inc. are anticipated to witness significant organic revenue growth owing to wide product portfolio
Table Of Contents Chapter 1 Methodology 1.1 Research Methodology 1.1.1 Information procurement 1.2 Information or Data Analysis 1.3 Market Formulation & Validation 1.4 Region Wise Market Calculation 1.4.1 Region wise market: base estimates 1.4.2 Global market: CAGR calculation 1.5 Region Based Segment Share Calculation 1.6 List of Secondary Sources 1.7 List of Primary Sources Chapter 2 Executive Summary 2.1 Market Snapshot Chapter 3 Industry Outlook 3.1 Market Segmentation 3.2 Market Variable Analysis 3.2.1 Market driver analysis 3.2.1.1 Expanding application scope 3.2.1.1.1 Disease diagnoses 3.2.1.1.2 Drug discovery & development 3.2.1.2 Lucrative growth of sequencing Technology 3.2.1.3 Technological Innovations in Single cell analysis and Cell isolation 3.2.1.4 Rising Incidence of Cancer 3.2.2 Market restraint analysis 3.2.2.1 High cost of instruments 3.2.2.2 Higher penetration of conventional mode of gene & cell analysis 3.3 Penetration & Growth Prospect Mapping of Application, 2018 3.4 Business Environment Analysis tools 3.4.1 SWOT analysis, by PEST 3.4.2 Porter’s five forces analysis Chapter 4 Clinical Trial Analysis Chapter 5 Product Segment Analysis 5.1 Single cell analysis Market: Product Movement Analysis 5.2 Consumables 5.2.1 Consumables market, 2016 - 2027 (USD Million) 5.2.2 Reagents 5.2.2.1 Reagents market, 2016 - 2027 (USD Million) 5.2.3 assay kits 5.2.3.1 Assay kits market, 2016 - 2027 (USD Million) 5.2.5 Others 5.2.5.1 Others market, 2016 - 2027 (USD Million) 5.3 Instruments 5.3.1 Instruments market, 2016 - 2027 (USD Million) 5.3.2 Microscopes 5.3.2.1 Microscopes market, 2016 - 2027 (USD Million) 5.3.3 Haemocytometers 5.3.3.1 Haemocytometers market, 2016 - 2027 (USD Million) 5.3.4 Flow cytometers 5.3.4.1 Flow cytometers market, 2016 - 2027 (USD Million) 5.3.5 Next Generation Sequencing (NGS) systems 5.3.5.1 Next Generation Sequencing (NGS) system market, 2016 - 2027 (USD Million) 5.3.6 Polymerase Chain Reaction (PCR) instruments 5.3.6.1 Polymerase Chain Reaction (PCR) Instruments Market, 2016 - 2027 (USD Million) 5.3.7 High content screening systems 5.3.7.1 High content screening systems market, 2016 - 2027 (USD Million) 5.3.8 Cell microarrays 5.3.8.1 Cell microarrays market, 2015 - 2027 (USD Million) 5.3.9 Automated cell counters 5.3.9.1 Automated cell counters market, 2016 - 2027 (USD Million) 5.3.10 Single live cell imaging 5.3.10.1 Single live cell imaging market, 2016 - 2027 (USD Million) Chapter 6 Application Segment Analysis 6.1 Single cell analysis Market: Application Movement Analysis 6.2 Cancer 6.2.1 Cancer market, 2016 - 2027 (USD Million) 6.3 Immunology 6.3.1 Immunology market, 2016 - 2027 (USD Million) 6.4 Neurology 6.4.1 Neurology market, 2016 - 2027 (USD Million) 6.5 Stem Cell 6.5.1 Stem cell market, 2016 - 2027 (USD Million) 6.6 Non-invasive Prenatal Diagnosis 6.6.1 Non-invasive prenatal diagnosis market, 2016 - 2027 (USD Million) 6.7 In-vitro Fertilization 6.7.1 In-Vitro Fertilization Market, 2016 - 2027 (USD Million) Chapter 7 End-use Segment Analysis 7.1 Single cell Analysis Market: End-use Movement Analysis 7.2 Academic & Research Laboratories 7.2.1 Academic & research laboratories market, 2016 - 2027 (USD Million) 7.3 Biotechnology and Pharmaceutical Companies 7.3.1 Biotechnology and pharmaceutical companies market, 2016 - 2027 (USD Million) 7.4 Hospitals and diagnostic laboratories 7.4.1 Hospitals and diagnostic laboratories market, 2016 - 2027 (USD Million) 7.5 Others 7.5.1 Other end-users market, 2016 - 2027 (USD Million) Chapter 8 Regional Outlook 8.1 Single cell Analysis Market Share by Region, 2019 & 2027 8.2 North America 8.2.1 North America Single cell analysis market, 2016 - 2027 (USD Million) 8.2.2 U.S. 8.2.2.1 U.S. Single cell analysis market, by product, 2016 - 2027 (USD Million) 8.2.2.2 U.S. Single cell analysis market, by application, 2016 - 2027 (USD Million) 8.2.2.3 U.S. Single cell analysis market, by end-use, 2016 - 2027 (USD Million) 8.2.3 Canada 8.2.3.1 Canada Single cell analysis market, by product, 2016 - 2027 (USD Million) 8.2.3.2 Canada Single cell analysis market, by application, 2016 - 2027 (USD Million) 8.2.3.3 Canada Single cell analysis market, by end-use, 2016 - 2027 (USD Million) 8.3 Europe 8.3.1 Europe Single cell analysis market, 2016 - 2027 (USD Million) 8.3.2 U.K. 8.3.2.1 U.K. Single cell analysis market, by product, 2016 - 2027 (USD Million) 8.3.2.2 U.K. Single cell analysis market, by application, 2016 - 2027 (USD Million) 8.3.2.3 U.K. Single cell analysis market, by end-use, 2016 - 2027 (USD Million) 8.3.3 Germany 8.3.3.1 Germany Single cell analysis market, by product, 2016 - 2027 (USD Million) 8.3.3.2 Germany Single cell analysis market, by application, 2016 - 2027 (USD Million) 8.3.3.3 Germany Single cell analysis market, by end-use, 2016 - 2027 (USD Million) 8.4 Asia Pacific 8.4.1 Asia Pacific Single cell analysis market, 2016 - 2027 (USD Million) 8.4.2 China 8.4.2.1 China Single cell analysis market, by product, 2016 - 2027 (USD Million) 8.4.2.2 China Single cell analysis market, by application, 2016 - 2027 (USD Million) 8.4.2.3 China Single cell analysis market, by end-use, 2016 - 2027 (USD Million) 8.4.3 India 8.4.3.1 India Single cell analysis market, by product, 2016 - 2027 (USD Million) 8.4.3.2 India Single cell analysis market, by application, 2016 - 2027 (USD Million) 8.4.3.3 India Single cell analysis market, by end-use, 2016 - 2027 (USD Million) 8.5 Latin America 8.5.1 Latin America Single cell analysis market, 2016–2027 (USD Million) 8.5.2 Brazil 8.5.2.1 Brazil Single cell analysis market, by product, 2016 - 2027 (USD Million) 8.5.2.2 Brazil Single cell analysis market, by application, 2016 - 2027 (USD Million) 8.5.2.3 Brazil Single cell analysis market, by end-use, 2016 - 2027 (USD Million) 8.5.3 Mexico 8.5.3.1 Mexico Single cell analysis market, by product, 2016 - 2027 (USD Million) 8.5.3.2 Mexico Single cell analysis market, by application, 2016 - 2027 (USD Million) 8.5.3.3 Mexico Single cell analysis market, by end-use, 2016 - 2027 (USD Million) 8.6 Middle East and Africa (MEA) 8.6.1 MEA Single cell analysis market, 2016–2027 (USD Million) 8.6.2 South Africa 8.6.2.1 South Africa Single cell analysis market, by product, 2016 - 2027 (USD Million) 8.6.2.2 South Africa Single cell analysis market, by application, 2016 - 2027 (USD Million) 8.6.2.3 South Africa Single cell analysis market, by end-use, 2016 - 2027 (USD Million) Chapter 9 Company Profiles 9.1 Thermo Fisher Scientific, Inc. 9.1.1 Company overview 9.1.2 Financial performance 9.1.3 Product benchmarking 9.1.4 Strategic initiatives 9.2 QIAGEN N.V. 9.2.1 Company overview 9.2.2 Financial performance 9.2.3 Product/service benchmarking 9.2.4 Strategic initiatives 9.3 Bio-Rad Laboratories, Inc. 9.3.1 Company overview 9.3.2 Financial performance 9.3.3 Product/service benchmarking 9.3.4 Strategic initiatives 9.4 Illumina, Inc. 9.4.1 Company overview 9.4.1 Financial performance 9.4.2 Product benchmarking 9.4.3 Strategic initiatives 9.5 Merck Millipore 9.5.1 Company overview 9.5.2 Financial performance 9.5.3 Product benchmarking 9.5.4 Strategic initiatives 9.6 Becton, Dickinson & Company 9.6.1 Company overview 9.6.2 Financial performance 9.6.3 Product benchmarking 9.6.4 Strategic initiatives 9.7 Fluidigm 9.7.1 Company overview 9.7.2 Financial performance 9.7.3 Product benchmarking 9.7.4 Strategic initiatives 9.8 10x Genomics, Inc. 9.8.1 Company overview 9.8.2 Financial performance 9.8.3 Product benchmarking 9.8.4 Strategic initiatives 9.9 BGI 9.9.1 Company overview 9.9.2 Financial performance 9.9.3 Product benchmarking 9.9.4 Strategic initiatives 9.10 Novogene Corporation 9.10.1 Company overview 9.10.2 Financial performance 9.10.3 Product benchmarking 9.10.4 Strategic initiatives
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook